| Application no. and date | 05849954.2 (espacenet) (Federated) (European Patent Register), 20051215 | | Patent/reg. no. and date | DK/EP 1830833, 20100127 | | Publication date | 20070912 | | Priority no. and date | US 636575 P, 20041216 | | EP pub. no. and date |
EP 1830833 20070912 | | Effective date | | | Applicant/owner | JANSSEN PHARMACEUTICA N.V., Turnhoutseweg 30
2340 Beerse, BE | | Applicant ref. no. | 137954 | | Inventor | MOYER, John, Allen, 5077 Rosewood Drive
Buck County, PA 18901, US,
ASHTON, David, Paterstraat 7
B-2300 Turnhout, BE,
KALIVAS, Peter, 167 Ashley Avenue,Suite 607
Charleston, SC 29425, US,
KLITENICK, Mark, 155 Candlewick Lane
Bridgewater, NJ 08807, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/341 (2006.01) , A61K 31/381 (2006.01) , A61K 31/517 (2006.01) , A61K 45/06 (2006.01) , A61P 25/18 (2006.01) | | Title | Kombination af en glycintransportør (GLyT1) inhibitor og et antipsykotikum til behandling af symptomer på schizofreni samt dens fremstilling og anvendelse deraf | | Int. application no. | US2005045749 | | Int. publication no. | WO2006066121 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
